Riya is interested in leveraging synthetic biology and metabolic engineering tools towards enabling more efficient bioproduction platforms for desirable compounds or therapeutic products. After graduating with a B.E. in Chemical and Biomolecular Engineering from Vanderbilt University, Riya spent three years working in Cell Culture Process Development at Gilead Sciences, where she developed and optimized mammalian cell culture biomanufacturing processes for therapeutic monoclonal antibodies (mAbs).